Can every patient be mobilized?

Best Practice and Research: Clinical Haematology

Volumn 23, Issue 4, 2010, Pages 519-523

  Dipersio, John F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allogeneic; Autologous; G CSF; GM CSF; Plerixafor; Stem cell mobilization

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; N [1,4,8,11 TETRAAZACYCLOTETRADECANYL 1,4 PHENYLENEBIS(METHYLENE)] 2 (AMINOMETHYL)PYRIDINE; NATALIZUMAB; PLERIXAFOR; SORAFENIB; STROMAL CELL DERIVED FACTOR 1;

CD34 SELECTION; CELL INTERACTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; LEUKEMIA CELL; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; STEM CELL; STEM CELL MOBILIZATION; SURVIVAL TIME;

ANTI-HIV AGENTS; ANTIGENS, CD34; CELL COMMUNICATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HETEROCYCLIC COMPOUNDS; HUMANS; RECEPTORS, CXCR4; STROMAL CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 78649969472     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2010.09.011     Document Type: Review

References (22)

1. J.P. Levesque, J. Hendy, and I.G. Winkler Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells Exp Hematol 31 2003 109 117
2. K. Ishiga, T. Kawatani, and F. Tajima Serum-soluble c-kit levels during mobilization of peripheral blood stem cells correlate with stem cell yield Int J Hematol 72 2000 186 193
3. Y. Nakamura, F. Tajima, and K. Ishiga Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice Exp Hematol 32 2004 390 396
4. T. Papayannopoulou, and B. Nakamoto Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin Proc Natl Acad Sci U S A 90 1993 9374 9378
5. F. Zohren, D. Toutzaris, and V. Klarner The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans Blood 111 2008 3893 3895
6. J.P. Levesque, Y. Takamatsu, and S.K. Nilsson Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor Blood 98 2001 1289 1297
7. J.P. Levesque, J. Hendy, and Y. Takamatsu Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment Exp Hematol 30 2002 440 449
8. K.W. Christopherson, S. Cooper, and H.E. Broxmeyer Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells Blood 101 2003 4680 4686
9. L.B. To, D.N. Haylock, and P.J. Simmons The biology and clinical uses of blood stem cells Blood 89 1997 2233 2258
10. L.N. Gordan, M.W. Sugrue, and J.W. Lynch Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation Leuk Lymphoma 44 2003 815 820
11. V. Pavone, F. Gaudio, and G. Console Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation Bone Marrow Transplant 37 2006 719 724
12. A.K. Blystad, J. Delabie, and S. Kvaloy Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy Br J Haematol 125 2004 605 612
13. D. O'Shea, C. Giles, and E. Terpos Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients Bone Marrow Transplant 37 2006 731 737
14. A.A. Toor, J. Ayers, and J. Strupeck Favourable results with a single autologous stem cell transplant following conditioning with busulphan and cyclophosphamide in patients with multiple myeloma Br J Haematol 124 2004 769 776
15. B.J. Bolwell, B. Pohlman, and L. Rybicki Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies Bone Marrow Transplant 40 2007 437 441
16. I. Pusic, S.Y. Jiang, and S. Landua Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation Biol Blood Marrow Transplant 14 2008 1045 1056
17. H.E. Broxmeyer, C.M. Orschell, and D.W. Clapp Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist J Exp Med 201 2005 1307 1318
18. W.C. Liles, H.E. Broxmeyer, and E. Rodger Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist Blood 102 2003 2728 2730
19. J.F. DiPersio, I.N. Micallef, and P.J. Stiff Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma J Clin Oncol 27 2009 4767 4773
20. S.M. Devine, R. Vij, and M. Rettig Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction Blood 112 2008 990 998
21. H. Bonig, A. Wundes, and K.-H. Chang Hematopoietic stem/progenitor cells (HSPC) mobilization parameters in patients chronically treated with the CD49d blocking antibody natalizumab Blood 110 2007 60a (abstr 177)
22. C.N. Abboud Another nail in the AML coffin Blood 113 2009 6045 6046